Most marketed drugs are not optimized for their full potential; more than 60% have problems with solubility, permeability or both.
More than 60% of marketed drugs are potential targets for improvement.
These drugs are not utilized to their full potential.
Sarfez Pharmaceuticals is developing innovative technologies that improve underperforming medications.
The hallmarks of our strategy are modest investments, lower risks and short development duration.
Sarfez Pharmaceuticals is committed to providing improved drugs at affordable prices.